Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 7,101 |
|
|||||
| News | (1) | ||||||
| Day High | 1.28 | Low High |
|||||
| Day Low | 1.255 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Biodesix Inc | BDSX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.02 | -1.56% | 1.26 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.28 | 1.255 | 1.28 | 1.26 | 1.28 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 130 | 7,101 | $ 1.26 | $ 8,982 | - | 1.03 - 2.21 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:00:00 | 451 | $ 1.26 | USD |
Biodesix Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 122.15M | 96.94M | - | 49.09M | -52.15M | -0.54 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Biodesix News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BDSX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.23 | 1.30 | 1.18 | 1.26 | 43,366 | 0.03 | 2.44% |
| 1 Month | 1.44 | 1.55 | 1.15 | 1.36 | 261,190 | -0.18 | -12.50% |
| 3 Months | 2.02 | 2.21 | 1.15 | 1.47 | 145,287 | -0.76 | -37.62% |
| 6 Months | 1.55 | 2.21 | 1.15 | 1.61 | 121,431 | -0.29 | -18.71% |
| 1 Year | 1.64 | 2.21 | 1.03 | 1.56 | 98,713 | -0.38 | -23.17% |
| 3 Years | 17.18 | 17.905 | 0.955 | 3.17 | 166,584 | -15.92 | -92.67% |
| 5 Years | 13.59 | 31.99 | 0.955 | 5.08 | 164,277 | -12.33 | -90.73% |
Biodesix Description
| Biodesix Inc is a data-driven diagnostic solutions company. Its artificial intelligence-based platform helps to discover, develop, and commercialize solutions for clinical unmet needs, with a focus on lung disease. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics. |
